Mohammad H Pourgholami
Overview
Explore the profile of Mohammad H Pourgholami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ataie-Kachoie P, Badar S, Morris D, Pourgholami M
Mol Cancer Res
. 2024 Apr;
22(4):415.
PMID: 38562062
No abstract available.
2.
Mahboobifard F, Pourgholami M, Jorjani M, Dargahi L, Amiri M, Sadeghi S, et al.
Biomed Pharmacother
. 2022 Oct;
156:113808.
PMID: 36252357
Over the last two decades, it has become evident that estrogens preserve the integrity of energy homeostasis at central and peripheral levels. Estrogen deficiency, such as that caused by menopause...
3.
Bahrami F, Mekkawy A, Badar S, Morris D, Pourgholami M
Am J Cancer Res
. 2021 Jul;
11(6):3098-3110.
PMID: 34249447
In women, epithelial ovarian cancer is the leading cause of gynaecological malignancy-related deaths. Development of resistance to standard platinum and taxane based chemotherapy and recurrence of the disease necessitate development...
4.
Mahboobifard F, Dargahi L, Jorjani M, Ramezani Tehrani F, Pourgholami M
Pharmacol Res
. 2020 Nov;
163:105307.
PMID: 33246174
Exploring the regulatory effects of estrogen on different body organs via its receptors is largely of interest. Recently, the expression, signaling and the clinical significance of ERα36, the newly identified...
5.
Kim Y, Pourgholami M, Morris D, Lu H, Stenzel M
Biomater Sci
. 2020 Jun;
1(3):265-275.
PMID: 32481852
Uptake of drug-loaded micelles by tumour cell lines can be the crucial step in the creation of an efficient drug delivery system. Crosslinking of micelles has increasingly been proposed as...
6.
Mahboobifard F, Bidari-Zerehpoosh F, Davoudi Z, Panahi M, Dargahi L, Pourgholami M, et al.
Pituitary
. 2020 Feb;
23(3):232-245.
PMID: 32026205
Purpose: The regulatory effects of estradiol on pituitary homeostasis have been well documented. However, the expression patterns of ERα66 and ERα36 and their correlations with the clinical course of postoperative...
7.
Pillai K, Pourgholami M, Chua T, Morris D
Am J Clin Oncol
. 2015 Jul;
38(4):388-94.
PMID: 26214083
Objectives: Although Ki67 measurement by immunohistochemistry has been widely used as a prognostic index in cancers, it has not been reported in malignant peritoneal mesothelioma (MPM). Hence, this study examines...
8.
Ataie-Kachoie P, Pourgholami M, Bahrami-B F, Badar S, Morris D
Am J Cancer Res
. 2015 May;
5(2):575-88.
PMID: 25973298
Hypoxia-inducible factor (HIF)-1α is the key cellular survival protein under hypoxia, and is associated with tumor progression and angiogenesis. We have recently shown the inhibitory effects of minocycline on ovarian...
9.
Noorani L, Stenzel M, Liang R, Pourgholami M, Morris D
J Nanobiotechnology
. 2015 Apr;
13:25.
PMID: 25890381
Background: The poor prognosis of patients with drug resistant ovarian cancer and the lack of targeted therapy have raised the need for alternative treatments. Albendazole (ABZ) is an anti-parasite compound...
10.
Bahrami F, Pourgholami M, Mekkawy A, Rufener L, Morris D
Am J Cancer Res
. 2014 Sep;
4(5):558-71.
PMID: 25232497
We have recently shown that the novel anthelmintic drug monepantel (MPL) inhibits growth, proliferation and colony formation, arrests the cell cycle and induces cleavage of PARP-1 in ovarian cancer cell...